IMR Press / FBE / Special Issues / 1328642816191021103
Cellular therapy and vaccine development
Submission deadline: 31 December 2011
Special Issue Editors
Garnet Suck
Research Scientist -, Centre for Transfusion Medicine, 11 Outram Road, Singapore 169078
Interests: 13 publications, 2 grants, Editor of Managing Editor - Frontiers in Bioscience
Special Issue and Collections in IMR journals
Keywords
Cell Biology
Molecular Biology
Technology
Therapeutics
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (1 Paper)
Open Access Article
KHYG-1 and NK-92 represent different subtypes of LFA-1-mediated NK cell adhesiveness
Garnet Suck, Suet-Mien Tan, Sixian Chu, Madelaine Niam, ... Mickey B. C. Koh
Front. Biosci. (Elite Ed) 2011, 3(1), 166–178; https://doi.org/10.2741/E230
(This article belongs to the Special Issue Cellular therapy and vaccine development)
33
Download
3
Citations
21
Views
Back to top